Suvoda Executive and Leadership Team

Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Suvoda's transformation of clinical trials through advanced technology, ensuring the Interactive Response Technology (IRT) system effectively addresses complex patient randomization and supply chain challenges. Wanninayake oversees the development and deployment of configurable and customizable features, powerful reporting, and advanced functionality designed for innovative study designs. The Chief Executive Officer's focus remains on empowering biopharmaceutical companies and clinical research organizations worldwide, fostering an environment of exceptional customer and advisory services. By driving innovation, Jagath Wanninayake ensures Suvoda maintains its position as a leader in the SaaS health technology sector, supporting studies of all sizes and complexities across global markets.

Brian Greenfield, the Chief Financial Officer at Suvoda, manages the company's financial health and strategic fiscal planning. This critical role involves overseeing all financial operations, including budgeting, forecasting, accounting, and financial reporting, ensuring robust fiscal management for Suvoda's innovative SaaS platform. Greenfield's responsibilities encompass financial strategy development, capital allocation, and risk management, directly supporting the company's growth and operational expansion in the clinical trial technology sector. The Chief Financial Officer ensures financial compliance and optimizes financial performance to support the delivery of advanced Interactive Response Technology (IRT) systems that solve complex patient randomization and supply chain challenges. By providing clear financial insights, Brian Greenfield enables informed decision-making across all departments, reinforcing Suvoda's commitment to providing exceptional services to biopharmaceutical companies and clinical research organizations globally.

John Samar, the Chief Financial Officer & Founder at Suvoda, provides foundational financial leadership and strategic direction. This role encompasses guiding the company's financial strategy and ensuring fiscal responsibility as Suvoda continues to innovate in the clinical trial technology space. Samar's deep understanding of the company's origins informs financial planning, supporting the development and deployment of the Interactive Response Technology (IRT) system. The Chief Financial Officer & Founder's oversight ensures that financial resources are effectively allocated to address complex patient randomization and supply chain challenges, benefiting biopharmaceutical companies and clinical research organizations. By maintaining a strong financial framework, John Samar contributes to Suvoda's mission of transforming clinical trials and supporting complex study designs globally.

Jp Samar, the Chief Financial Officer & Founder at Suvoda, contributes essential financial oversight and strategic guidance. This executive role involves ensuring the financial stability and growth of Suvoda's innovative SaaS solutions for clinical trials. Samar's founding perspective shapes financial decision-making, supporting the robust functionality of the Interactive Response Technology (IRT) system. The Chief Financial Officer & Founder's responsibilities include managing financial operations to effectively tackle complex patient randomization and supply chain challenges for a global clientele. By upholding rigorous financial standards, Jp Samar supports Suvoda's commitment to transforming clinical trials and empowering biopharmaceutical companies and clinical research organizations with advanced technology.

Robert Hummel, the Chief Operating Officer at Suvoda, directs the company's day-to-day operational activities and ensures seamless service delivery. This executive position involves optimizing internal processes, managing global operations, and enhancing the efficiency of Suvoda's technology solutions for clinical trials. Hummel oversees the implementation and support of the Interactive Response Technology (IRT) system, ensuring it effectively addresses complex patient randomization and clinical trial supply chain challenges for customers worldwide. The Chief Operating Officer's focus is on maintaining high standards of customer and advisory services, supporting biopharmaceutical companies and clinical research organizations of all sizes. By driving operational excellence, Robert Hummel ensures Suvoda's ability to support complex and innovative study designs, contributing directly to the company's mission of transforming clinical trials through technology and reliable execution across all its global offices.

Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, leads the company's strategic initiatives and operational execution within the Japanese market. This key leadership position involves driving the adoption and success of Suvoda's clinical trial technology solutions across Japan, ensuring alignment with global objectives. Fukasaku oversees the expansion of Suvoda's Interactive Response Technology (IRT) system, focusing on addressing the unique needs and complexities of Japanese biopharmaceutical companies and clinical research organizations. The President, Suvoda (Japan)'s responsibilities include fostering strong local partnerships and delivering exceptional customer and advisory services tailored to the region. By championing Suvoda's mission, Yuko Fukasaku ensures the company's advanced functionality and support for complex study designs are effectively implemented, contributing to the transformation of clinical trials in Japan.

Elena Filimonova, the Chief Marketing Officer at Suvoda, architects and executes the global marketing strategy. This position involves driving brand awareness and market penetration for Suvoda's innovative SaaS solutions in clinical trial technology. Filimonova oversees all aspects of marketing, including digital campaigns, content strategy, product marketing, and lead generation, ensuring alignment with the company's mission to transform clinical trials. The Chief Marketing Officer's responsibilities extend to communicating the value proposition of Suvoda's Interactive Response Technology (IRT) system, highlighting its ability to solve complex patient randomization and supply chain challenges. By fostering strong customer relationships and understanding market needs, Elena Filimonova ensures Suvoda's offerings resonate with biopharmaceutical companies and clinical research organizations of all sizes, supporting complex and innovative study designs across diverse geographical regions.